August 6, 2020
The IMF will host the 11th Annual International Myeloma Working Group (IMWG) Summit August 25-26. Focused, as always, on the latest myeloma research from experts around the world, the IMWG Summit will be held online this year due
Although we cannot meet in person, the IMWG will continue its tradition of programming excellence. We are particularly honored and excited to kick things off this year with a keynote lecture by Dr. Kári Stefánsson, a leading figure in human genetics. Dr. Stefánsson, founder and CEO of deCODE genetics in Iceland, has been interviewed by CNN and The New Yorker magazine, among others, about Iceland’s COVID-19 research. His IMWG Summit lecture is entitled “Clonal Expansions in Health and Disease.”
In addition to top research presentations, the Summit agenda will feature reports by several “working groups,” small teams whose members meet during the Summit to review the latest findings in a range of current subjects, such as: CAR T-cell therapy and other immune therapy approaches; when to treat smoldering myeloma; the status of MRD; and improving patient access to new drugs. These reviews are followed by concise summaries of key points, along with guidance in the way forward.
Investigators from the IMF’s Black Swan Research Initiative® (BSRI) team will also meet to move ahead in IMF’s signature effort to cure myeloma, an effort that continues in the face of the current pandemic.
I look forward to the presentation of the IMF’s 18th Annual IMWG Awards, conferred during the Summit. These are well-deserved. Thierry Facon, M.D. will receive the Robert A. Kyle Lifetime Achievement Award. This award honors an individual whose body of work has made significant contributions to myeloma research and patient care. And Wee Joo Chng, MD will receive the IMF Brian Durie Outstanding Achievement Award, which recognizes excellence in myeloma research.
During these past few months, the IMF team has been working hard to convert what has always been an in-person event to one that is exclusively online. Despite the challenges, we believe it is extremely important to help keep myeloma research momentum going.
IMF President and CEO Susie Novis Durie says, “The IMF is proud to lead this collaborative event that brings together the world’s experts in myeloma to advance treatment and research that will lead to a cure."
Dr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.